Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
PagoNxt cross-border going-private tender offers for Getnet securities
We advised PagoNxt on the tender offers by which it took Getnet private
Verisk $500 million senior notes offering
We advised Verisk on the SEC-registered notes
Cigna $1.5 billion senior notes offering
The senior notes are due 2026 and 2033
Mirion Technologies $85.6 million secondary offering
The offering consists of 9,786,153 shares of Class A common stock
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
SMFG $1.3 billion senior notes reopening
We advised SMFG on its offering of TLAC notes
Black Hills $350 million senior notes offering
The 5.950% notes are due 2028
KeySpan Gas East $500 million senior notes offering
The 5.994% notes are due 2033
Encore Capital Group $230 million convertible senior notes offering
The convertible and exchangeable senior notes are due 2029 and 2023
Hayward Holdings $214 million secondary offering
The stock is listed on the NYSE